Sterne, Kessler, Goldstein & Fox P.L.L.C.
Aryl substituted benzimidazoles and their use as sodium channel blockers
This invention relates aryl substituted benzimidazoles of Formula I: or a pharmaceutically acceptable salt, prodrug or solvate thereof, wherein R1, R2, R10 and n are defined in the specification. The invention is also directed to the use of compounds of Formula I for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and for the treatment, prevention or amelioration of both acute or chronic pain, as antitinnitus agents, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy.
Euro-Celtique S.A.
A A A A C A A A A C A A A A A C
A61P A61P A61P A61P C07D A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Xiaoming Donald J. Qun
Zhou Kyle Sun